These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24112999)

  • 41. A prospective, randomized, double-blind study assessing the clinical impact of integrated pharmacogenomic testing for major depressive disorder.
    Winner JG; Carhart JM; Altar CA; Allen JD; Dechairo BM
    Discov Med; 2013 Nov; 16(89):219-27. PubMed ID: 24229738
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Classical conditioning of antidepressant placebo effects in mice.
    Krimmel SR; Zanos P; Georgiou P; Colloca L; Gould TD
    Psychopharmacology (Berl); 2020 Jan; 237(1):93-102. PubMed ID: 31422429
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Learning to experience side effects after antidepressant intake - Results from a randomized, controlled, double-blind study.
    Rheker J; Winkler A; Doering BK; Rief W
    Psychopharmacology (Berl); 2017 Feb; 234(3):329-338. PubMed ID: 27807605
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Midline and right frontal brain function as a physiologic biomarker of remission in major depression.
    Cook IA; Hunter AM; Abrams M; Siegman B; Leuchter AF
    Psychiatry Res; 2009 Nov; 174(2):152-7. PubMed ID: 19853417
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prefrontal changes and treatment response prediction in depression.
    Cook IA; Leuchter AF
    Semin Clin Neuropsychiatry; 2001 Apr; 6(2):113-20. PubMed ID: 11296311
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of clinical neurophysiology for the selection of medication in the treatment of major depressive disorder: the state of the evidence.
    Leuchter AF; Cook IA; Hunter A; Korb A
    Clin EEG Neurosci; 2009 Apr; 40(2):78-83. PubMed ID: 19534301
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The promise of the quantitative electroencephalogram as a predictor of antidepressant treatment outcomes in major depressive disorder.
    Hunter AM; Cook IA; Leuchter AF
    Psychiatr Clin North Am; 2007 Mar; 30(1):105-24. PubMed ID: 17362807
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The change of prefrontal QEEG theta cordance as a predictor of response to bupropion treatment in patients who had failed to respond to previous antidepressant treatments.
    Bares M; Brunovsky M; Novak T; Kopecek M; Stopkova P; Sos P; Krajca V; Höschl C
    Eur Neuropsychopharmacol; 2010 Jul; 20(7):459-66. PubMed ID: 20421161
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rostral anterior cingulate cortex theta current density and response to antidepressants and placebo in major depression.
    Korb AS; Hunter AM; Cook IA; Leuchter AF
    Clin Neurophysiol; 2009 Jul; 120(7):1313-9. PubMed ID: 19539524
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute effects of the novel antidepressant venlafaxine on cognitive event-related potentials (P300), eye blink rate and mood in young healthy subjects.
    Semlitsch HV; Anderer P; Saletu B; Binder GA; Decker KA
    Int Clin Psychopharmacol; 1993; 8(3):155-66. PubMed ID: 8263313
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Calcitonin-induced impairment in conditioning is antagonized by chronic antidepressant drug treatment.
    Aboufatima R; Chait A; Dalal A; de Beaurepaire R
    Therapie; 1999; 54(5):573-7. PubMed ID: 10667092
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Classically conditioned changes of blood glucose level in humans.
    Fehm-Wolfsdorf G; Gnadler M; Kern W; Klosterhalfen W; Kerner W
    Physiol Behav; 1993 Jul; 54(1):155-60. PubMed ID: 8327595
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of drug tolerability on the selection of antidepressant treatment in patients with major depressive disorder.
    Ginsberg LD
    CNS Spectr; 2009 Dec; 14(12 Suppl 12):8-14. PubMed ID: 20397586
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Response to Pharmacological Treatment in Major Depression Predicted by Electroencephalographic Alpha Power - a Pilot Naturalistic Study.
    Kandilarova SS; Terziyski KV; Draganova AI; Stoyanov DS; Akabaliev VH; Kostianev SS
    Folia Med (Plovdiv); 2017 Sep; 59(3):318-325. PubMed ID: 28976896
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acquisition of Conditioning between Methamphetamine and Cues in Healthy Humans.
    Cavallo JS; Mayo LM; de Wit H
    PLoS One; 2016; 11(8):e0161541. PubMed ID: 27548681
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Habituation and conditioning: Salience change in associative learning.
    Hall G; Rodríguez G
    J Exp Psychol Anim Learn Cogn; 2017 Jan; 43(1):48-61. PubMed ID: 28045294
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of childhood maltreatment on outcomes of antidepressant medication in chronic and/or recurrent depression.
    Medeiros GC; Prueitt WL; Rush AJ; Minhajuddin A; Czysz AH; Patel SS; Trombello J; Trivedi MH
    J Affect Disord; 2021 Aug; 291():39-45. PubMed ID: 34023746
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Conditioning of amitriptyline-induced REM sleep suppression in healthy participants: A randomized controlled trial.
    Winkler A; Rheker J; Doering BK; Rief W
    Psychophysiology; 2016 Oct; 53(10):1560-6. PubMed ID: 27354202
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Classically conditioned responses following repeated insulin and glucose administration in humans.
    Stockhorst U; Steingrüber HJ; Scherbaum WA
    Behav Brain Res; 2000 Jun; 110(1-2):143-59. PubMed ID: 10802311
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dynamic Feedback Between Antidepressant Placebo Expectancies and Mood.
    Peciña M; Chen J; Karp JF; Dombrovski AY
    JAMA Psychiatry; 2023 Apr; 80(4):389-398. PubMed ID: 36857039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.